13:12 · 11 May 2026 Medicare’s Low Uptake of New Alzheimer’s Drugs Leaves Spending Forecasts Unchanged Medicare’s spending projections for new Alzheimer’s drugs Leqembi and Kisunla have been slashed due to minimal uptake, with no significant spending ex...